Home LiteratureArticle Details
PMID: 26849170 Published · ppublish English

Evaluation of the antineoplastic activity of gallic acid in oral squamous cell carcinoma under hypoxic conditions.

Anti-cancer drugs ·Vol. 27 ·No. 5 ·2016-08-16

Guimaraes Talita A, Farias Lucyana C, Fraga Carlos A, Feltenberger John D, Melo Geraldo A, Coletta Ricardo D, Souza Santos Sergio H, de Paula Alfredo M B, Guimaraes Andre L

Abstract

The purpose of the current study was to develop and test a theoretical model that could explain the mechanism of action of gallic acid (GA) in the oral squamous cell carcinoma context for the first time. The theoretical model was developed using bioinformatics and interaction network analysis to evaluate the effect of GA on oral squamous cell carcinoma. In a second step to confirm theoretical results, migration, invasion, proliferation, and gene expression (Col1A1, E-cadherin, HIF-1α, and caspase-3) were performed under normoxic and hypoxic conditions. Our study indicated that treatment with GA resulted in the inhibition of cell proliferation, migration, and invasion in neoplastic cells. Observation of the molecular mechanism showed that GA upregulates E-cadherin expression and downregulates Col1A1 and HIF-1α expression, suggesting that GA might be a potential anticancer compound. In conclusion, the present study demonstrated that GA significantly reduces cell proliferation, invasion, and migration by increasing E-cadherin and repressing Col1A1.

Article Info
Journal
Anti-cancer drugs
Abbr.
Anticancer Drugs
Published
2016-08-16
Indexed
2016-04-06
Updated
2016-04-06
Language
English
Country/Region
England
NLM ID
9100823
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]